The DIAMA project is assessing and validating the Deeplex® Myc-TB test in Africa and Europe. This rapid molecular test (based on mass sequencing) detects and genotypes mycobacteria and predicts antituberculosis drug resistance in Mycobacterium tuberculosis complex strains.
Partners:
- Centre National Hospitalier de Pneumo-Phtisiologie – Benin,
- Prins Leopold Instituut voor Tropische Geneeskunde – Belgium (Bruxelles),
- Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) – Mali,
- London School of Hygiene and Tropical Medicine (LSHTM) – United Kingdom (London),
- Service de Pneumophtisiologie de l’Hôpital National Ignace Deen – Guinea,
- Jimma University – Ethiopia,
- Université Catholique de Louvain (UCL) – Belgium (Louvain),
- The Bamenda Center for Health Promotion and Research – Cameroun,
- Institute National of Research Biomedical of Zaire (INRB) – Congo,
- Damien Foundation – Belgium (Bruxelles),
- Rwanda Biomedical Center (RBC) – Rwanda,
- University Cheikh Anta Diop – Senegal,
- World Health Organization (WHO).
Funding:
